Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Pediatric Hematology/Oncology|November 1, 1992
Mass screening of neuroblastoma in Sapporo City, JapanM Nishi, H Miyake, T Takeda, et al.
Nihon Naibunpi Gakkai Zasshi|February 20, 1987
[Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 2. Analysis of steroids with high-performance liquid chromatography for diagnosis of congenital adrenal hyperplasia]Y Mizushima, M Fukushi, O Arai, et al.
Clinical Endocrinology|December 23, 1998
Gestational transient hyperthyroxinaemia (GTH): screening for thyroid function in 23,163 pregnant women using dried blood spotsS Tanaka, H Yamada, E H Kato, et al.
The Tohoku Journal of Experimental Medicine|August 1, 1987
A simple method for quantification of biotinidase activity in dried blood spot and its application to screening of biotinidase deficiencyA Yamaguchi, M Fukushi, O Arai, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1992
Syntheses of 2-(3,4-dimethoxyphenyl)ethylamine derivatives and their antiulcer activitiesT Hosokami, M Kuretani, K Higashi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2010
Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout lifeN Sugiya, A Nakashima, N Takasugi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 1999
C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilinT Tomita, R Takikawa, A Koyama, et al.
The Journal of Biological Chemistry|July 4, 2001
The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilinsT Tomita, T Watabiki, R Takikawa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1984
Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tabletsH Ogata, N Aoyagi, K Kaniwa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1984
Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution ratesH Ogata, N Aoyagi, N Kaniwa, et al.
Pageof 10